SCHEMBL29348349

SCHEMBL29348349

CNc1ccc(-c2cccc(C3CCC(=O)NC3=O)c2Cl)cc1C

nearest known ligand 0.50

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
DDB1 Q16531 16/20 0.50
CRBN Q96SW2 16/20 0.50
BRD4 O60885 4/20 0.36
CREBBP Q92793 4/20 0.36
GSPT1 P15170 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29348363 0.85 DDB1 (0.52) DDB1CRBNBRD4CREBBP
SCHEMBL29348366 0.84 DDB1 (0.49) DDB1CRBNGSPT1
SCHEMBL29348364 0.81 DDB1 (0.50) DDB1CRBNBRD4CREBBP
SCHEMBL29348370 0.78 DDB1 (0.46) DDB1CRBNBRD4CREBBP
SCHEMBL29348340 0.78 DDB1 (0.46) DDB1CRBNBRD4
SCHEMBL31068241 0.78 DDB1 (0.56) DDB1CRBN
SCHEMBL29348362 0.78 CRBN (0.55) DDB1CRBN
SCHEMBL31068286 0.78 CREBBP (0.44) DDB1CRBNBRD4CREBBP
SCHEMBL31068156 0.78 DDB1 (0.44) DDB1CRBNBRD4CREBBP
SCHEMBL29348689 0.78 DDB1 (0.44) DDB1CRBNBRD4CREBBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024151547-A1 TARGETED DEGRADATION OF VAV1 MONTE ROSA THERAPEUTICS, INC. (US) 2024-07-18 WO disclosed